SCHEMBL6164595

SCHEMBL6164595

CC1(C)CC(=O)c2c(C(C)(C)C)nn(-c3ccccn3)c2C1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CCNA2 P20248 6/20 0.47
CDK2 P24941 6/20 0.47
CCNO P22674 1/20 0.47
CCNE1 P24864 1/20 0.47
CCNA1 P78396 1/20 0.47
OPRM1 P35372 11/20 0.46
HSP90AB1 P08238 1/20 0.42
ALDH1A1 P00352 2/20 0.41
MAPT P10636 1/20 0.41
THRB P10828 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
HPGD P15428 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6162861 0.84 OPRM1 (0.65) CCNA2CDK2CCNOCCNE1CCNA1
SCHEMBL6165217 0.83 OPRM1 (0.53) CCNA2CDK2OPRM1HSP90AB1ALDH1A1
SCHEMBL6167069 0.81 CCNA2 (0.47) CCNA2CDK2CCNOCCNE1CCNA1
SCHEMBL6167327 0.81 ALDH1A1 (0.48) CCNA2CDK2CCNOCCNE1CCNA1
SCHEMBL6164703 0.81 OPRM1 (0.45) CCNA2CDK2CCNOCCNE1CCNA1
SCHEMBL6162155 0.80 OPRM1 (0.57) CCNA2CDK2CCNOCCNE1CCNA1
SCHEMBL6166206 0.80 OPRM1 (0.42) CCNA2CDK2CCNOCCNE1CCNA1
SCHEMBL6167358 0.79 ALDH1A1 (0.57) CCNA2CDK2CCNOCCNE1CCNA1
SCHEMBL6164726 0.79 CCNA2 (0.47) CCNA2CDK2CCNOCCNE1CCNA1
SCHEMBL6167734 0.78 OPRM1 (0.49) CCNA2CDK2OPRM1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed